Food Noise in Obesity: Current Evidence, Measurement, and Clinical Implications

Food noise has emerged as a patient-derived term describing frequent, persistent, or intrusive food-related thoughts that may be unwanted, distressing, or disruptive.Although the expression has rapidly entered public discourse, particularly alongside reports of appetite changes during glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment, its scientific boundaries remain unsettled.This narrative review summarizes current definitions, epidemiologic observations, measurement instruments, proposed mechanisms, differential diagnosis, and responses to obesity interventions.Two dedicated instruments have been published: the five-item Food Noise Questionnaire (FNQ) and the Ro Allison Indiana Dhurandhar Food Noise Inventory (RAID-FN).Both demonstrate promising initial psychometric properties, but neither has established diagnostic thresholds, minimal clinically important differences, predictive validity, or sufficient evidence of responsiveness to treatment.Consumer surveys and selected cross-sectional studies suggest that burdensome food-related cognition is common in some populations; however, representative prevalence estimates are unavailable.Randomized trials show that glucagon-like peptide-1-based therapies reduce appetite, cravings, food-cue reactivity, and energy intake, whereas direct evidence of reduced food noise is currently limited primarily to retrospective and cross-sectional observations.Food noise should therefore be regarded as an emerging clinical dimension rather than a diagnosis, biomarker, or validated treatment target.Prospective studies using validated instruments are required to determine whether it provides information beyond established constructs and whether its reduction independently predicts weight-management, mental-health, or quality-of-life outcomes.